Abstract

Pediatric Health Care: An Introduction

Author(s): Williams LaVonn A

Issue: Jan/Feb 2013 - Volume 17, Number 1

Page(s): 6-8

Download in electronic PDF format for $75
  • Pediatric Health Care: An Introduction Page 1
  • Pediatric Health Care: An Introduction Page 2
  • Pediatric Health Care: An Introduction Page 3

Abstract

Pediatric healthcare, to include compounded medications, is achallenge for healthcare providers. Although current studies have provided important new informationabout drug safety and effectiveness for children, carrying outstudies in children is difficult. Age-appropriate equipment and medical techniques, along with specialists who are sensitive to a child’s concerns, are a must. Therefore, experts must build a foundationand resources that are needed to conduct studies involving pediatric patients. Compounding pharmacists welcome reliable data from which to use when compounding medications for such an elite group of patients.

Related Keywords

  • children
  • child
  • infants
  • drug safety
  • dosages
  • off-label medication use
  • loratidine
  • fentanyl
  • fluvoxamine maleate
  • midazolam hydrochloride
  • gabapentin
  • famotidine
  • sevoflurane
  • United States Food and Drug Administration
  • FDA

Related Categories

  • LEGAL
  • PEDIATRICS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2013
Pg. 6-8
Pediatric Health Care: An Introduction
Author(s): Williams LaVonn A
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Sep/Oct 2006
Pg. 390
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 220-225
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 451-458
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
May/Jun 2016
Pg. 247-249
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Author(s): Nahata Milap C
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Sep/Oct 2017
Pg. 364-370
Child-safety Containers/Devices and Compounding
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Jul/Aug 2002
Pg. 286-287
Medications Discontinued in the United States
Author(s): Ashworth Lisa D
May/Jun 2019
Pg. 182-186
How to Develop and Maintain a Hazardous Drug List
Author(s): Dillon L Rad
Sep/Oct 2018
Pg. 358-366
Current Trends and Emerging Priorities in Compounded Preparations for Children
Author(s): Parrish Richard H II
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Jan/Feb 2009
Pg. 14-18
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
May/Jun 2006
Pg. 175-183
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M